Are SPACs Better Than Traditional IPOs?
Published: Mar 10, 2021 By Kate Goodwin
Outcome Capital’s Managing Director Paul Mieyal, Ph.D., CFA was interviewed by BioSpace for his views on the recent popularity of SPACs in the biotech space. The interview covers historical perspective, current market dynamics, and outlook for the next year.
News
Averra Holdings and Banner Capital Announce Partnership with ZIEN Medical
PR Newswire / June 16, 2025 SALT LAKE CITY, June 16, 2025 /PRNewswire/ — Averra Holdings, LLC (“Averra”), a portfolio company of Banner Capital, is pleased to announce a partnership with ZIEN Medical Technologies (“ZIEN”). Read More
Read MoreResources
Outcome Capital Life Science Market Pulse, May 2025
Outcome Capital Life Science Market Pulse May 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
